Канада - английски - Health Canada

recordati rare diseases canada inc - pasireotide (pasireotide diaspartate) - solution - 0.3mg - pasireotide (pasireotide diaspartate) 0.3mg - somatostatin agonists

Канада - английски - Health Canada

recordati rare diseases canada inc - pasireotide (pasireotide diaspartate) - solution - 0.6mg - pasireotide (pasireotide diaspartate) 0.6mg - somatostatin agonists

Канада - английски - Health Canada

recordati rare diseases canada inc - pasireotide (pasireotide diaspartate) - solution - 0.9mg - pasireotide (pasireotide diaspartate) 0.9mg - somatostatin agonists

Малайзия - английски - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fta healthcare sdn. bhd. - pasireotide diaspartate -

Малайзия - английски - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fta healthcare sdn. bhd. - pasireotide diaspartate -

Малайзия - английски - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fta healthcare sdn. bhd. - pasireotide diaspartate -

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pasireotide diaspartate 0.3762 mg/ml equivalent to pasireotide 0.3 mg/ml - solution for injection - 300 mcg/ml - active: pasireotide diaspartate 0.3762 mg/ml equivalent to pasireotide 0.3 mg/ml excipient: mannitol nitrogen sodium hydroxide tartaric acid water for injection - the treatment of adult patients with cushing's disease for whom surgery is not an option or for whom surgery has failed.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pasireotide diaspartate 0.7524 mg/ml equivalent to pasireotide 0.6 mg/ml - solution for injection - 600 mcg/ml - active: pasireotide diaspartate 0.7524 mg/ml equivalent to pasireotide 0.6 mg/ml excipient: mannitol nitrogen sodium hydroxide tartaric acid water for injection - the treatment of adult patients with cushing's disease for whom surgery is not an option or for whom surgery has failed.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pasireotide diaspartate 1.1286 mg/ml equivalent to pasireotide 0.9 mg/ml - solution for injection - 900 mcg/ml - active: pasireotide diaspartate 1.1286 mg/ml equivalent to pasireotide 0.9 mg/ml excipient: mannitol nitrogen sodium hydroxide tartaric acid water for injection - the treatment of adult patients with cushing's disease for whom surgery is not an option or for whom surgery has failed.